Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

MeSH terms

• Analgesics / adverse effects
• Analgesics / classification
• Analgesics / pharmacology
• Analgesics / therapeutic use
• Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
• Anti-Inflammatory Agents, Non-Steroidal / classification
• Anti-Inflammatory Agents, Non-Steroidal / pharmacology
• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
• Cardiotonic Agents / pharmacology
• Cardiotonic Agents / therapeutic use
• Cardiovascular Diseases / chemically induced*
• Cardiovascular Diseases / prevention & control
• Cyclooxygenase 2 Inhibitors / adverse effects
• Cyclooxygenase 2 Inhibitors / therapeutic use
• Disease Management
• Drug Interactions
• Drug Labeling
• Duty to Warn
• Edema / chemically induced
• Gastrointestinal Hemorrhage / chemically induced
• Gastrointestinal Hemorrhage / prevention & control
• Humans
• Hypertension / chemically induced
• Kidney Diseases / chemically induced
• Musculoskeletal Diseases / drug therapy
• Pain / drug therapy
• Platelet Aggregation Inhibitors / pharmacology
• Platelet Aggregation Inhibitors / therapeutic use
• Prostaglandin Antagonists / adverse effects
• Prostaglandin Antagonists / therapeutic use
• Randomized Controlled Trials as Topic
• Stroke / chemically induced*
• Stroke / prevention & control
• Thrombosis / chemically induced
• Thrombosis / prevention & control
• United States
• United States Food and Drug Administration